Maykin Ho, Ph.D.

Maykin Ho, Ph.D.

DirectoratNeumora Therapeutics· In proxies 2023–2025

Maykin Ho, Ph.D. sits on 5 public boards.

Boards1

  • Neumora TherapeuticsDirector · 3 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Neumora TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -98%
  2. BioMarin PharmaceuticalPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Agios PharmaceuticalsPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  4. Annual Meeting of StockholdersPublic company
    • Director? – PresentNo stock prices for these years
  5. GRAILPublic company · 2 yr
    • Director2019 – 2021 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?